Skip to main content

Glossary


Gilles Capart
Is the Managing Director of BruCells and has managed the Company since incorporation. Until June 1999, Gilles was Vice President of Investments and IP of the UCB Group, a worldwide chemical and pharmaceutical company headquartered in Brussels. Gilles has managed Sopartec, the seed capital and knowledge transfer company of UCL and the seed capital fund VIVES. He has also served as Chairman of ProTon Europe, the pan-European network of Knowledge Transfer from Public Research. Gilles holds a PhD in Physics and a Master in Business Administration.